Publications

Inflammatory bowel diseases

CD151 Regulates T-Cell Migration in Health and Inflammatory Bowel Disease.

01-02-2016

Oncoimmunology

Systemic inflammation: Cancer's long-distance reach to maximize metastasis.

01-02-2016

Nature biotechnology

Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9.

01-02-2016

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Correlates of physical activity among colorectal cancer survivors: results from the longitudinal population-based profiles registry.

01-02-2016

Genetics in medicine : official journal of the American College of Medical Genetics

Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial.

01-02-2016

Cancer treatment reviews

Risk of subsequent gastrointestinal cancer among childhood cancer survivors: A systematic review.

01-02-2016

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy.

01-02-2016

Journal of virology

A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection.

01-02-2016

Investigational new drugs

Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study.

01-02-2016

Journal of pharmaceutical and biomedical analysis

Liquid chromatography-tandem mass spectrometric assay for the simultaneous determination of the irreversible BTK inhibitor ibrutinib and its dihydrodiol-metabolite in plasma and its application in mouse pharmacokinetic studies.

25-01-2016

Autophagy

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

23-01-2016

Journal for immunotherapy of cancer

Novel technologies and emerging biomarkers for personalized cancer immunotherapy.

21-01-2016

J Clin Oncol.

Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma

20-01-2016

Radiation oncology (London, England)

Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.

20-01-2016

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.

20-01-2016

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis.

20-01-2016

British journal of cancer

Gene-environment interaction and risk of breast cancer.

19-01-2016

Oncotarget

An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.

19-01-2016

Oncotarget

Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer.

19-01-2016

Methods in enzymology

Preface.

19-01-2016

Clinical cancer research : an official journal of the American Association for Cancer Research

Real-time In Vivo Tissue Characterization with Diffuse Reflectance Spectroscopy during Transthoracic Lung Biopsy: A Clinical Feasibility Study.

15-01-2016

Clinical cancer research : an official journal of the American Association for Cancer Research

Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy.

15-01-2016

Clinical cancer research : an official journal of the American Association for Cancer Research

SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer.

15-01-2016

Oncotarget

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.

12-01-2016

British journal of cancer

Employment and social benefits up to 10 years after breast cancer diagnosis: a population-based study.

12-01-2016

Cancer cell

Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.

11-01-2016

The Journal of biological chemistry

Structure of UBE2Z Enzyme Provides Functional Insight into Specificity in the FAT10 Protein Conjugation Machinery.

08-01-2016

Nature communications

BAP1/ASXL1 recruitment and activation for H2A deubiquitination.

07-01-2016

Scientific reports

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.

05-01-2016

Cancers

Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer.

02-01-2016

Molecular cancer therapeutics

High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer.

01-01-2016

Clinical cancer research : an official journal of the American Association for Cancer Research

Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors.

01-01-2016

Head & neck

Psychometric properties of 3 patient-reported outcome measures for the assessment of shoulder disability after neck dissection.

01-01-2016

Biochimica et biophysica acta

Tumor antigens in human cancer control.

01-01-2016

European journal of cancer (Oxford, England : 1990)

Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.

01-01-2016

The British journal of surgery

Radioactive seed localization in breast cancer treatment.

01-01-2016

Psycho-oncology

Reliable change in neuropsychological assessment of breast cancer survivors.

01-01-2016

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Confounding of the Association between Radiation Exposure from CT Scans and Risk of Leukemia and Brain Tumors by Cancer Susceptibility Syndromes.

01-01-2016

The Lancet. Oncology

Actual costs of cancer drugs in 15 European countries.

01-01-2016

International journal of cancer

Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G to C substitution in the first 28-bp tandem repeat of the thymidylate synthase 2R allele.

01-01-2016

Journal of clinical epidemiology

Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust.

01-01-2016

Molecular oncology

4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.

01-01-2016

The Prostate

Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation.

01-01-2016

Human genetics

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.

01-01-2016

Nuclear medicine and biology

Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).

01-01-2016

Gynecologic oncology

Prediction of incomplete primary debulking surgery in patients with advanced ovarian cancer: An external validation study of three models using computed tomography.

01-01-2016

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Development of an item bank for computerized adaptive test (CAT) measurement of pain.

01-01-2016

The New England Journal of Medicine

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

24-12-2015

The New England journal of medicine

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.

24-12-2015

Cureus

Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?

24-12-2015

CD151 Regulates T-Cell Migration in Health and Inflammatory Bowel Disease.

Systemic inflammation: Cancer's long-distance reach to maximize metastasis.

Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9.

Correlates of physical activity among colorectal cancer survivors: results from the longitudinal population-based profiles registry.

Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial.

Risk of subsequent gastrointestinal cancer among childhood cancer survivors: A systematic review.

Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy.

A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection.

Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study.

Liquid chromatography-tandem mass spectrometric assay for the simultaneous determination of the irreversible BTK inhibitor ibrutinib and its dihydrodiol-metabolite in plasma and its application in mouse pharmacokinetic studies.

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

Novel technologies and emerging biomarkers for personalized cancer immunotherapy.

Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma

Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.

Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis.

Gene-environment interaction and risk of breast cancer.

An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.

Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer.

Preface.

Real-time In Vivo Tissue Characterization with Diffuse Reflectance Spectroscopy during Transthoracic Lung Biopsy: A Clinical Feasibility Study.

Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy.

SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer.

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.

Employment and social benefits up to 10 years after breast cancer diagnosis: a population-based study.

Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.

Structure of UBE2Z Enzyme Provides Functional Insight into Specificity in the FAT10 Protein Conjugation Machinery.

BAP1/ASXL1 recruitment and activation for H2A deubiquitination.

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.

Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer.

High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer.

Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors.

Psychometric properties of 3 patient-reported outcome measures for the assessment of shoulder disability after neck dissection.

Tumor antigens in human cancer control.

Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.

Radioactive seed localization in breast cancer treatment.

Reliable change in neuropsychological assessment of breast cancer survivors.

Confounding of the Association between Radiation Exposure from CT Scans and Risk of Leukemia and Brain Tumors by Cancer Susceptibility Syndromes.

Actual costs of cancer drugs in 15 European countries.

Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G to C substitution in the first 28-bp tandem repeat of the thymidylate synthase 2R allele.

Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust.

4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.

Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation.

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.

Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).

Prediction of incomplete primary debulking surgery in patients with advanced ovarian cancer: An external validation study of three models using computed tomography.

Development of an item bank for computerized adaptive test (CAT) measurement of pain.

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.

Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?

This site uses cookies